Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to evaluate the efficacy and safety of supra-early
post-surgery chemotherapy versus standard TEMODAL® regimen in treatment of patients with
newly diagnosed glioblastoma multiforme. The secondary purpose is to assess the efficacy of
supra-early post-surgery chemotherapy in release brain edema.